STING1 and atherosclerosis: Presently, Amlexanox, a medication utilized for treating ulcers and asthma, has been observed to inhibit TBK1 phosphorylation at Ser366, effectively mitigating the negative effects of STING activation in mouse models of atherosclerosis and AAD (Luo et al. 2020; Pham et al. 2021; Zhou et al. 2020).